BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22949777)

  • 1. Remission of chronic anthracycline-induced heart failure with support from a continuous-flow left ventricular assist device.
    Khan N; Husain SA; Husain SI; Khalaf N; George J; Raissi F; Segura AM; Kar B; Bogaev RC; Frazier OH
    Tex Heart Inst J; 2012; 39(4):554-6. PubMed ID: 22949777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthracycline treatment and ventricular remodeling in left ventricular assist device patients.
    Segura AM; Radovancevic R; Demirozu ZT; Frazier OH; Buja LM
    Tex Heart Inst J; 2015 Apr; 42(2):124-30. PubMed ID: 25873821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission of chronic, advanced heart failure after left ventricular unloading with an implantable left ventricular assist device.
    Demirozu ZT; Frazier OH
    Tex Heart Inst J; 2012; 39(2):268-70. PubMed ID: 22740750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery from anthracycline-induced cardiomyopathy with biventricular assist and valve repairs: A case report and literature review.
    Takami Y; Hoshino N; Kato Y; Sakurai Y; Amano K; Higuchi Y; Tochii M; Ishida M; Ishikawa H; Takagi Y; Ozaki Y
    Int J Artif Organs; 2018 Jul; 41(7):413-417. PubMed ID: 29806528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular assist device as bridge to recovery for anthracycline-induced terminal heart failure.
    Appel JM; Sander K; Hansen PB; Møller JE; Krarup-Hansen A; Gustafsson F
    Congest Heart Fail; 2012; 18(5):291-4. PubMed ID: 22521037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report and review of the literature: the utilisation of a ventricular assist device as bridge to recovery for anthracycline-induced ventricular dysfunction.
    Krasnopero D; Asante-Korang A; Jacobs JP; Stapleton S; Carapellucci J; Dotson M; Stapleton G
    Cardiol Young; 2018 Mar; 28(3):471-475. PubMed ID: 29198224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of left ventricular assist device application for chemotherapy-related cardiomyopathy caused by trastuzumab and anthracycline.
    Inui T; Kohno H; Matsuura K; Ueda H; Tamura Y; Watanabe M; Inage Y; Yakita Y; Matsumiya G
    J Artif Organs; 2020 Sep; 23(3):270-274. PubMed ID: 31897739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure in remission for more than 13 years after removal of a left ventricular assist device.
    Segura AM; Dris L; Massin EK; Clubb FJ; Buja LM; Frazier OH; Taegtmeyer H
    Tex Heart Inst J; 2014 Aug; 41(4):389-94. PubMed ID: 25120391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Titanium Plug Closure after HeartWare Ventricular Assist Device Explantation in a 15-Year-Old Girl: First U.S. Experience.
    Lara DA; Jeewa A; Elias BA; McCullum EO; Denfield SW; Dreyer WJ; Adachi I
    Tex Heart Inst J; 2017 Feb; 44(1):66-69. PubMed ID: 28265217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute chemotherapy-induced cardiomyopathy treated with intracorporeal left ventricular assist device in an 8-year-old child.
    Schweiger M; Dave H; Lemme F; Cavigelli-Brunner A; Romanchenko O; Heineking B; Hofmann M; Bürki C; Stiasny B; Hübler M
    ASAIO J; 2013; 59(5):520-2. PubMed ID: 23995994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and functional cardiac profile after prolonged duration of mechanical unloading: potential implications for myocardial recovery.
    Castillero E; Ali ZA; Akashi H; Giangreco N; Wang C; Stöhr EJ; Ji R; Zhang X; Kheysin N; Park JS; Hegde S; Patel S; Stein S; Cuenca C; Leung D; Homma S; Tatonetti NP; Topkara VK; Takeda K; Colombo PC; Naka Y; Sweeney HL; Schulze PC; George I
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1463-H1476. PubMed ID: 30141986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular reconditioning and pump explantation in patients supported by continuous-flow left ventricular assist devices.
    Frazier OH; Baldwin AC; Demirozu ZT; Segura AM; Hernandez R; Taegtmeyer H; Mallidi H; Cohn WE
    J Heart Lung Transplant; 2015 Jun; 34(6):766-72. PubMed ID: 25447571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Ventricular Tachycardia Ablation Using Percutaneous Left Ventricular Assist Devices.
    Kusa S; Miller MA; Whang W; Enomoto Y; Panizo JG; Iwasawa J; Choudry S; Pinney S; Gomes A; Langan N; Koruth JS; d'Avila A; Reddy VY; Dukkipati SR
    Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28576780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthracycline-induced cardiomyopathy: favourable effects of cardiac resynchronization therapy.
    Ahlehoff O; Galløe AM; Hansen PR
    Int J Cardiol; 2010 Jul; 142(2):e23-4. PubMed ID: 19135740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological findings in cardiac apex removed during implantation of left ventricular assist devices (LVAD) are non-specific: 13-year-experience at a German Heart Center.
    Strecker T; Rösch J; Weyand M; Agaimy A
    Int J Clin Exp Pathol; 2014; 7(9):5549-56. PubMed ID: 25337196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microaxial Flow Left Ventricular Assist Device as a Bridge to Transplantation after LVAD Malfunction.
    Reich HJ; Shah A; Azarbal B; Kobashigawa J; Moriguchi J; Czer L; Esmailian F
    Tex Heart Inst J; 2015 Dec; 42(6):572-4. PubMed ID: 26664315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Who would be a candidate for bridge to recovery during prolonged mechanical left ventricular support in idiopathic dilated cardiomyopathy?
    Matsumiya G; Monta O; Fukushima N; Sawa Y; Funatsu T; Toda K; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):699-704. PubMed ID: 16153916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ventricular assist device implantation as a bridge to cardiac transplantation in two adolescents with end-stage cardiomyopathy and heart failure as a result of anthracycline use].
    Berends M; van Bokhoven MM; van de Luijtgaarden A; Bellersen LB; van Hoesel QC; van Herpen CM
    Ned Tijdschr Geneeskd; 2008 Sep; 152(38):2088-92. PubMed ID: 18837186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; Garcia Saez D; Bireta C; Wahlers T; Karck M; Kallenbach K; Ruhparwar A; Fatullayev J; Amrani M; De Robertis F; Bahrami T; Popov AF; Simon AR
    Artif Organs; 2015 Apr; 39(4):336-42. PubMed ID: 25345547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
    Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.